J Pediatr Intensive Care 2020; 09(01): 074-076
DOI: 10.1055/s-0039-1700522
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Reperfusion Injury with Compartment Syndrome Following Systemic Thrombolysis for Cardiac Catheterization-Related Arterial Thrombosis in an Infant

Dyan Zhewei Zhang
1   Cardiology Service, Department of Paediatric Subspecialties, KK Women's and Children's Hospital, Singapore, Singapore
,
Teng Hong Tan
1   Cardiology Service, Department of Paediatric Subspecialties, KK Women's and Children's Hospital, Singapore, Singapore
,
Kenneth Pak Leung Wong
2   Department of Orthopaedic Surgery, KK Women's and Children's Hospital, Singapore, Singapore
,
Sreekanthan Sundaraghavan
1   Cardiology Service, Department of Paediatric Subspecialties, KK Women's and Children's Hospital, Singapore, Singapore
,
Jonathan Tze Liang Choo
1   Cardiology Service, Department of Paediatric Subspecialties, KK Women's and Children's Hospital, Singapore, Singapore
› Institutsangaben
Weitere Informationen

Publikationsverlauf

02. Juni 2019

19. September 2019

Publikationsdatum:
01. November 2019 (online)

Abstract

Systemic thrombolysis is increasingly used for management of arterial thrombosis following cardiac catheterization, and complications apart from bleeding manifestations are not well reported. We report the case of an infant with lower limb ischemia secondary to femoral arterial thrombosis, which developed after cardiac catheterization. Systemic thrombolysis resulted in successful reperfusion of the lower limb. However, the infant subsequently developed compartment syndrome, requiring an emergent fasciotomy. This case highlights the importance of surveillance for the development of reperfusion injury-related compartment syndrome postsystemic thrombolysis for arterial thrombosis.

 
  • References

  • 1 Ansah DA, Patel KN, Montegna L, Nicholson GT, Ehrlich AC, Petit CJ. Tissue plasminogen activator use in children: bleeding complications and thrombus resolution. J Pediatr 2016; 171: 67-72.e1-2
  • 2 Gupta AA, Leaker M, Andrew M. , et al. Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children. J Pediatr 2001; 139 (05) 682-688
  • 3 Newall F, Browne M, Savoia H, Campbell J, Barnes C, Monagle P. Assessing the outcome of systemic tissue plasminogen activator for the management of venous and arterial thrombosis in pediatrics. J Pediatr Hematol Oncol 2007; 29 (04) 269-273
  • 4 Vitiello R, McCrindle BW, Nykanen D, Freedom RM, Benson LN. Complications associated with pediatric cardiac catheterization. J Am Coll Cardiol 1998; 32 (05) 1433-1440
  • 5 Freed MD, Keane JF, Rosenthal A. The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children. Circulation 1974; 50 (03) 565-569
  • 6 Mongale P, Chan AKC, Goldenberg NA. , et al. Antithrombotic Therapy in Neonates and Children: Antithrombotic Therapy and Prevention of Thrombosis. 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. CHEST 2012; 141 (2 Suppl): e737S-e801S
  • 7 Brus F, Witsenburg M, Hofhuis WJ, Hazelzet JA, Hess J. Streptokinase treatment for femoral artery thrombosis after arterial cardiac catheterisation in infants and children. Br Heart J 1990; 63 (05) 291-294
  • 8 Zenz W, Muntean W, Beitzke A, Zobel G, Riccabona M, Gamillscheg A. Tissue plasminogen activator (alteplase) treatment for femoral artery thrombosis after cardiac catheterisation in infants and children. Br Heart J 1993; 70 (04) 382-385
  • 9 Albisetti M. Thrombolytic therapy in children. Thromb Res 2006; 118 (01) 95-105
  • 10 Eltzschig HK, Collard CD. Vascular ischaemia and reperfusion injury. Br Med Bull 2004; 70: 71-86
  • 11 Abouezzi Z, Nassoura Z, Ivatury RR, Porter JM, Stahl WM. A critical reappraisal of indications for fasciotomy after extremity vascular trauma. Arch Surg 1998; 133 (05) 547-551
  • 12 Beyersdorf F, Matheis G, Krüger S. , et al. Avoiding reperfusion injury after limb revascularization: experimental observations and recommendations for clinical application. J Vasc Surg 1989; 9 (06) 757-766